Ventricular Event Pause Detection for SVT vs VT/VF Discrimination

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing medical devices struggle to accurately discriminate between supraventricular tachyarrhythmia (SVT) and ventricular tachyarrhythmia (VT/VF) due to insufficient heart rate-based criteria, leading to potential inappropriate electrical stimulation therapies.

Innovation Solution

A medical device system that detects a pause in the rate of sensed ventricular events and analyzes cardiac electrical signal morphology to differentiate SVT from VT/VF, thereby withholding or delaying VT/VF detection and therapy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If heart rate-based criteria alone are used for tachyarrhythmia detection, then detection simplicity is maintained, but discrimination accuracy between SVT and VT/VF deteriorates

Engineering Contradiction:
Improvedetection simplicityVSAvoiddiscrimination accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent segments the tachyarrhythmia detection process into multiple independent analysis components: (1) heart rate criteria evaluation, (2) pause detection in ventricular event rate, (3) morphology analysis of cardiac electrical signals, and (4) conduction ratio assessment. Each segment evaluates a specific aspect, and their combined results enable accurate SVT vs. VT/VF discrimination while maintaining operational simplicity through automated multi-parameter assessment.

Inventive Principle:
Principle #1Segmentation

2Speed

If electrical stimulation therapy is delivered based on insufficient discrimination criteria, then treatment response time is improved, but inappropriate therapy delivery occurs

Engineering Contradiction:
Improvetreatment response timeVSAvoidtherapy appropriateness
Core Design Contradiction:
SpeedVSReliability

Solution Approach 1:

The patent performs preliminary discrimination analysis by detecting pauses in ventricular event rate and analyzing cardiac electrical signal morphology before confirming VT/VF and initiating therapy. This preliminary action includes evaluating multiple parameters (heart rate, pause presence, morphology features) to pre-assess the likelihood of SVT versus VT/VF, ensuring that electrical stimulation therapy is only delivered when VT/VF is confidently identified, thereby preventing inappropriate therapy while maintaining rapid response capability.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS20250339691A1Supraventricular tachyarrhythmia discrimination
Publication Date: 2025.11.06 MEDTRONIC INC
  • US20250339691A1 patent drawing
  • US20250339691A1 patent drawing
  • US20250339691A1 patent drawing

AI summary

Techniques are described for discriminating SVT and, in particular, rapidly conducting AF. The techniques include detecting an onset of a fast rate of ventricular events sensed from a cardiac electrical signal and detecting a pause in the fast rate of ventricular sensed events. A threshold number of ventricular event intervals required to detect a ventricular tachyarrhythmia is detected with each of the threshold number of ventricular event intervals being less than a tachyarrhythmia detection interval. Detection of the ventricular tachyarrhythmia and an electrical stimulation therapy for treating the ventricular tachyarrhythmia are withheld in response to at least the pause being detected.